COMPREHENSIVE CROSS-DATABASE IDENTIFIER AND FUNCTIONAL MAPPING REFERENCE
Human TP53 (Tumor Protein P53)
Section 1: Gene Identifiers
Primary Gene Identifiers
| Database | Identifier | Description |
|---|
| HGNC | HGNC:11998 | Approved symbol: TP53 |
| Ensembl | ENSG00000141510 | Human gene |
| NCBI Entrez | 7157 | Gene ID |
| OMIM | 191170 | Gene/Locus ID |
Gene Names & Aliases
- Approved Name: tumor protein p53
- Aliases: p53, LFS1, BCC7, BMFS5, TRP53
Genomic Location (GRCh38/hg38)
| Attribute | Value |
|---|
| Chromosome | 17 |
| Cytoband | 17p13.1 |
| Start Position | 7,661,779 |
| End Position | 7,687,546 |
| Strand | Minus (-) |
| Genomic Accession | NC_000017.11 |
Gene Classification
| - Locus Type | - Locus Group | - Status |
|---|
| gene with protein product | protein-coding gene | Approved | |
| | | Transcript Identifiers** |
Ensembl Transcripts
Total Count: 39 transcripts
| Transcript ID | Biotype | Start | End | Notes |
|---|
| ENST00000269305 | protein_coding | 7,668,421 | 7,687,490 | Canonical/MANE Select |
| ENST00000359597 | protein_coding | 7,666,086 | 7,676,594 | |
| ENST00000413465 | protein_coding | 7,661,779 | 7,676,594 | |
| ENST00000420246 | protein_coding | 7,668,404 | 7,687,481 | |
| ENST00000445888 | protein_coding | 7,668,421 | 7,687,487 | |
| ENST00000455263 | protein_coding | 7,668,404 | 7,687,481 | |
| ENST00000503591 | protein_coding | 7,668,421 | 7,687,427 | |
| ENST00000504290 | protein_coding | 7,668,402 | 7,675,493 | |
| ENST00000504937 | protein_coding | 7,668,402 | 7,675,493 | |
| ENST00000505014 | retained_intron | 7,674,526 | 7,687,487 | |
| ENST00000508793 | protein_coding | 7,668,413 | 7,677,578 | |
| ENST00000509690 | protein_coding | 7,668,421 | 7,687,487 | |
| ENST00000510385 | protein_coding | 7,668,402 | 7,675,493 | |
| ENST00000514944 | protein_coding | 7,668,421 | 7,687,427 | |
| ENST00000571370 | protein_coding_CDS_not_defined | 7,685,249 | 7,687,523 | |
| ENST00000574684 | protein_coding_CDS_not_defined | 7,674,254 | 7,675,119 | |
| ENST00000576024 | protein_coding | 7,668,421 | 7,687,511 | |
| ENST00000604348 | protein_coding | 7,668,421 | 7,687,487 | |
| ENST00000610292 | protein_coding | 7,668,402 | 7,687,481 | |
| ENST00000635293 | nonsense_mediated_decay | 7,665,416 | 7,687,491 | |
| ENST00000714356 | protein_coding | 7,665,963 | 7,677,515 | |
| ENST00000714408 | protein_coding | 7,668,421 | 7,687,490 | |
| ENST00000905353 | protein_coding | 7,669,550 | 7,686,160 | |
| ENST00000923566 | protein_coding | 7,668,423 | 7,686,413 | |
| ENST00000949117 | protein_coding | 7,668,417 | 7,687,490 | |
| (+14 more transcripts) | | | | |
RefSeq Transcripts (Human, Chromosome 17)
MANE Select (Canonical Clinical Standard):
- NM_000546 → NP_000537 ✓ MANE Select
Other RefSeq mRNA Transcripts (REVIEWED):
| RefSeq mRNA | RefSeq Protein |
|---|
| NM_001126112 | NP_001119584 |
| NM_001126113 | NP_001119585 |
| NM_001126114 | NP_001119586 |
| NM_001126115 | NP_001119587 |
| NM_001126116 | NP_001119588 |
| NM_001126117 | NP_001119589 |
| NM_001126118 | NP_001119590 |
| NM_001276695 | NP_001263624 |
| NM_001276696 | NP_001263625 |
| NM_001276697 | NP_001263626 |
| NM_001276698 | NP_001263627 |
| NM_001276699 | NP_001263628 |
| NM_001276760 | NP_001263689 |
| NM_001276761 | NP_001263690 |
| NM_001407262-NM_001407271 | NP_001394191-NP_001394200 |
CCDS Identifiers
Total: 12 CCDS entries
| CCDS ID |
|---|
| CCDS11118 (primary) |
| CCDS45605 |
| CCDS45606 |
| CCDS73963 |
| CCDS73964 |
| CCDS73965 |
| CCDS73966 |
| CCDS73967 |
| CCDS73968 |
| CCDS73969 |
| CCDS73970 |
| CCDS73971 |
Canonical Transcript Exons (ENST00000269305)
Total Exon Count: 11
| Exon ID | Start | End | Strand |
|---|
| ENSE00003753508 | 7,687,377 | 7,687,490 | - |
| ENSE00004023728 | 7,676,521 | 7,676,622 | - |
| ENSE00002419584 | 7,676,382 | 7,676,403 | - |
| ENSE00003625790 | 7,675,994 | 7,676,272 | - |
| ENSE00003518480 | 7,675,053 | 7,675,236 | - |
| ENSE00003723991 | 7,674,859 | 7,674,971 | - |
| ENSE00003712342 | 7,674,181 | 7,674,290 | - |
| ENSE00003725258 | 7,673,701 | 7,673,837 | - |
| ENSE00003786593 | 7,673,535 | 7,673,608 | - |
| ENSE00003545950 | 7,670,609 | 7,670,715 | - |
| ENSE00004023724 | 7,668,421 | 7,669,690 | - |
Section 3: Protein Identifiers
UniProt Accessions
Total: 19 entries
| UniProt ID | Type | Notes |
|---|
| P04637 | Reviewed (Swiss-Prot) | Canonical entry |
| A0A087WT22 | Unreviewed (TrEMBL) | Isoform |
| A0A087WXZ1 | Unreviewed (TrEMBL) | Isoform |
| A0A087X1Q1 | Unreviewed (TrEMBL) | Isoform |
| A0A0U1RQC9 | Unreviewed (TrEMBL) | Isoform |
| A0A386NBZ1 | Unreviewed (TrEMBL) | Isoform |
| A0AAQ5BHX5 | Unreviewed (TrEMBL) | Isoform |
| A0AAQ5BHY1 | Unreviewed (TrEMBL) | Isoform |
| A0AAQ5BHZ9 | Unreviewed (TrEMBL) | Isoform |
| E7EMR6 | Unreviewed (TrEMBL) | Isoform |
| E7EQX7 | Unreviewed (TrEMBL) | Isoform |
| E7ESS1 | Unreviewed (TrEMBL) | Isoform |
| E9PCY9 | Unreviewed (TrEMBL) | Isoform |
| E9PFT5 | Unreviewed (TrEMBL) | Isoform |
| H2EHT1 | Unreviewed (TrEMBL) | Isoform |
| I3L0W9 | Unreviewed (TrEMBL) | Isoform |
| J3KP33 | Unreviewed (TrEMBL) | Isoform |
| K7PPA8 | Unreviewed (TrEMBL) | Isoform |
| S4R334 | Unreviewed (TrEMBL) | Isoform |
Canonical Protein Properties (P04637)
| Property | Value |
|---|
| Name | Cellular tumor antigen p53 |
| Alternative Names | Phosphoprotein p53, Tumor suppressor p53, Antigen NY-CO-13 |
| Length | 393 amino acids |
| Mass | 43,653 Da |
Protein Domains and Families
InterPro Annotations (9 entries):
| InterPro ID | Name | Type |
|---|
| IPR002117 | p53_tumour_suppressor | Family |
| IPR011615 | p53_DNA-bd | Domain |
| IPR010991 | p53_tetrameristn | Domain |
| IPR013872 | p53_transactivation_domain | Domain |
| IPR040926 | p53_TAD2 | Domain |
| IPR057064 | P53_central_site | Conserved_site |
| IPR008967 | p53-like_TF_DNA-bd_sf | Homologous_superfamily |
| IPR012346 | p53/RUNT-type_TF_DNA-bd_sf | Homologous_superfamily |
| IPR036674 | p53_tetramer_sf | Homologous_superfamily |
Pfam Domains (4 entries):
| Pfam ID | Description |
|---|
| PF00870 | P53 DNA-binding domain |
| PF07710 | P53 tetramerization domain |
| PF08563 | P53 transactivation domain |
| PF18521 | P53 transactivation domain 2 |
Section 4: Structure Identifiers
Experimental Structures
Total PDB Structure Count: 297
Structure Methods Breakdown:
- X-ray Diffraction: ~250 structures
- Solution NMR: ~30 structures
- Cryo-EM (Electron Microscopy): ~15 structures
Representative High-Resolution Structures:
| PDB ID | Method | Resolution | Description |
|---|
| 1TSR | X-ray | 2.2 Å | P53 core domain in complex with DNA |
| 1TUP | X-ray | 2.2 Å | Tumor suppressor P53 complexed with DNA |
| 1YCR | X-ray | 2.6 Å | MDM2 bound to the transactivation domain of P53 |
| 2AC0 | X-ray | 1.8 Å | P53 tetramers bound to DNA |
| 3KMD | X-ray | 2.15 Å | P53 core domain bound to full consensus site |
| 3TS8 | X-ray | 2.8 Å | Multidomain p53 tetramer with CDKN1A response element |
| 4HJE | X-ray | 1.9 Å | P53 core domain in complex with DNA |
| 6XRE | Cryo-EM | 4.6 Å | P53/RNA polymerase II assembly |
| 7XZZ | Cryo-EM | 4.07 Å | Nucleosome in complex with p53 |
| 8UQR | X-ray | 1.22 Å | P53 tetramerization domain (highest resolution) |
TOP 50 PDB Structures (by resolution):
| PDB | Resolution | Method | Description |
|---|
| 9C5S | 1.01 Å | X-ray | P53-derived peptide dimer |
| 8UQR | 1.22 Å | X-ray | P53 tetramerization domain |
| 3D06 | 1.20 Å | X-ray | P53 R249S mutant |
| 6SHZ | 1.24 Å | X-ray | P53 Y220C mutant |
| 6GGC | 1.24 Å | X-ray | P53 Y220C + PK9320 stabilizer |
| 6GGE | 1.25 Å | X-ray | P53 Y220C + PK9327 |
| 3ZME | 1.35 Å | X-ray | P53 Y220C + PhiKan7242 |
| 5AOK | 1.35 Å | X-ray | P53 Y220C + PhiKan7099 |
| 5AB9 | 1.36 Å | X-ray | P53 Y220C + indole stabilizer |
| 8A92 | 1.37 Å | X-ray | P53 Y220C + pyrazole-amine |
| 8QWO | 1.38 Å | X-ray | P53 Y234C mutant |
| 7B4N | 1.32 Å | X-ray | Wild-type P53 + DNA + MQ |
| (+~285 more structures) | | | |
Predicted Structures
AlphaFold Model:
| Property | Value |
|---|
| AlphaFold ID | AF-P04637-F1 |
| Sequence Length | 3,060 (full length with isoforms) |
| Global pLDDT | 75.83 |
| Fraction Very High Confidence | 0.54 (54%) |
Section 5: Cross-Species Orthologs
| Organism | Ensembl Gene ID | Symbol | Biotype |
|---|
| Mouse (Mus musculus) | ENSMUSG00000059552 | Trp53 | protein_coding |
| Rat (Rattus norvegicus) | ENSRNOG00000010756 | Tp53 | protein_coding |
| Zebrafish (Danio rerio) | ENSDARG00000035559 | tp53 | protein_coding |
| Fruit fly (Drosophila melanogaster) | FBGN0039044 | p53 | protein_coding |
| Worm (C. elegans) | No direct ortholog | cep-1 | (p53-like, functional) |
| Yeast (S. cerevisiae) | No ortholog | - | (No p53 family members) |
Protein Sequence Similarity (DIAMOND, Top 20)
| UniProt ID | Species | Identity | BitScore |
|---|
| P56423 | Pongo abelii (orangutan) | 100% | 773 |
| P56424 | Pan troglodytes (chimp) | 100% | 773 |
| P61260 | Gorilla gorilla | 100% | 773 |
| P67938 | Macaca mulatta | 100% | 748 |
| P67939 | Macaca fascicularis | 100% | 748 |
| O88898 | Mus musculus | 99.6% | 1330 |
| Q9JJP6 | Rattus norvegicus | 99.6% | 1333 |
| O57538 | Mesocricetus auratus | 99.4% | 641 |
| Q92143 | Oryctolagus cuniculus | 99.4% | 641 |
| O36006 | Sus scrofa | 97.8% | 654 |
| Q64662 | Cricetulus griseus | 97.8% | 604 |
| O15350 | Homo sapiens (p63) | 97.5% | 1242 |
| Q9XSK8 | Homo sapiens (p73) | 97.5% | 1243 |
| P79892 | Felis catus | 94.6% | 444 |
| Q9TTA1 | Canis lupus familiaris | 93.1% | 709 |
| O09185 | Cavia porcellus | 91.2% | 707 |
| Q00366 | Ovis aries | 91.2% | 715 |
| Q9TUB2 | Bos taurus | 90.7% | 672 |
| Q8SPZ3 | Equus caballus | 90.7% | 673 |
| Q9JJP2 | Mus musculus (p63) | 88.8% | 1128 |
Section 6: Clinical Variants & AI Predictions
ClinVar Variant Summary
Total Variants: 3,850
| Classification | Count (est.) |
|---|
| Pathogenic | ~400+ |
| Likely Pathogenic | ~200+ |
| Pathogenic/Likely pathogenic | ~100+ |
| Uncertain Significance (VUS) | ~2,500+ |
| Likely Benign | ~300+ |
| Benign | ~100+ |
| Conflicting Classifications | ~200+ |
TOP 50 Pathogenic Variants (Expert-Reviewed Priority)
| ClinVar ID | HGVS | Protein Change | Review Status |
|---|
| 12347 | c.742C>T | p.Arg248Trp | Expert panel |
| 12356 | c.743G>A | p.Arg248Gln | Expert panel |
| 12365 | c.733G>A | p.Gly245Ser | Expert panel |
| 12366 | c.818G>A | p.Arg273His | Expert panel |
| 12374 | c.524G>A | p.Arg175His | Expert panel |
| 127814 | c.488A>G | p.Tyr163Cys | Expert panel |
| 127819 | c.659A>G | p.Tyr220Cys | Expert panel |
| 142536 | c.1009C>T | p.Arg337Cys | Expert panel |
| 142714 | c.711G>A | p.Met237Ile | Expert panel |
| 142766 | c.455C>T | p.Pro152Leu | Expert panel |
| 12357 | c.398T>C | p.Met133Thr | Multiple submitters |
| 12349 | c.733G>T | p.Gly245Cys | Multiple submitters |
| 12383 | c.659A>C | p.Tyr220Ser | Multiple submitters |
| 100815 | c.736A>G | p.Met246Val | Multiple submitters |
| 141141 | c.842A>G | p.Asp281Gly | Multiple submitters |
| 140821 | c.844C>G | p.Arg282Gly | Multiple submitters |
| 141377 | c.920-1G>A | Splice site | Multiple submitters |
| 1189743 | c.560-2A>C | Splice site | Multiple submitters |
| 1210292 | c.376-1G>T | Splice site | Multiple submitters |
| 1073381 | c.321C>G | p.Tyr107Ter | Multiple submitters |
| 1174012 | c.811G>T | p.Glu271Ter | Multiple submitters |
| 1075711 | c.958A>T | p.Lys320Ter | Multiple submitters |
| 1361331 | c.981T>A | p.Tyr327Ter | Multiple submitters |
| 142144 | c.916C>T | p.Arg306Ter | Multiple submitters |
| 1069305 | c.702C>G | p.Tyr234Ter | Multiple submitters |
| 127807 | c.328del | p.Arg110fs | Multiple submitters |
| 127809 | c.365_366del | p.Val122fs | Multiple submitters |
| 12377 | c.532del | p.His178fs | Multiple submitters |
| 1074338 | c.723del | p.Cys242fs | Multiple submitters |
| 1076652 | c.690del | p.Thr231fs | Multiple submitters |
| 1070469 | c.205del | p.Ala69fs | Multiple submitters |
| 1069225 | c.425del | p.Pro142fs | Multiple submitters |
| 1069265 | c.403del | p.Cys135fs | Multiple submitters |
| 1363662 | c.262del | p.Ala88fs | Multiple submitters |
| 1366432 | c.388del | p.Leu130fs | Multiple submitters |
| 1394451 | c.173del | p.Pro58fs | Multiple submitters |
| 1068830 | c.872_890dup | p.His297fs | Multiple submitters |
| 1319403 | c.148dup | p.Ile50fs | Multiple submitters |
| 1389237 | c.902dup | p.Gly302fs | Multiple submitters |
| 1391019 | c.945_946del | p.Gln317fs | Multiple submitters |
| 1400613 | c.768_769del | p.Leu257fs | Multiple submitters |
| 1447671 | c.80del | p.Pro27fs | Multiple submitters |
| 1421837 | c.489C>A | p.Tyr163Ter | Multiple submitters |
| 1026335 | c.476C>A | p.Ala159Asp | Multiple submitters |
| 1067825 | c.509_520del | p.Thr170_Val173del | Multiple submitters |
| 1024056 | c.687_695del | p.Thr230_Ile232del | Single submitter |
| 1045295 | c.653_655del | p.Val218_Pro219delinsAla | Single submitter |
| 1052035 | c.737_745del | p.Met246_Arg248del | Single submitter |
| 1067910 | c.472C>A | p.Arg158Ser | Single submitter |
| 1012210 | c.825T>A | p.Cys275Ter | Single submitter |
AlphaMissense Predictions
Total Missense Variants Assessed: 2,569
TOP 50 Predicted Pathogenic Missense Variants:
| Variant | Protein Change | AM Score | Classification |
|---|
| 17:7670670:C:G | A347P | 0.995 | likely_pathogenic |
| 17:7670714:A:C | I332S | 0.997 | likely_pathogenic |
| 17:7670678:A:G | L344P | 0.996 | likely_pathogenic |
| 17:7670714:A:G | I332T | 0.994 | likely_pathogenic |
| 17:7670714:A:T | I332N | 0.996 | likely_pathogenic |
| 17:7670696:A:G | F338S | 0.982 | likely_pathogenic |
| 17:7673539:A:G | L330P | 0.995 | likely_pathogenic |
| 17:7670709:C:G | G334R | 0.989 | likely_pathogenic |
| 17:7670708:C:A | G334V | 0.992 | likely_pathogenic |
| 17:7670708:C:T | G334E | 0.986 | likely_pathogenic |
| 17:7670684:C:G | R342P | 0.984 | likely_pathogenic |
| 17:7670699:C:G | R337P | 0.987 | likely_pathogenic |
| 17:7673539:A:T | L330H | 0.989 | likely_pathogenic |
| 17:7673539:A:C | L330R | 0.978 | likely_pathogenic |
| 17:7670700:G:T | R337S | 0.976 | likely_pathogenic |
| 17:7670678:A:T | L344Q | 0.974 | likely_pathogenic |
| 17:7670697:A:T | F338I | 0.971 | likely_pathogenic |
| 17:7670695:G:C | F338L | 0.993 | likely_pathogenic |
| 17:7673544:G:C | F328L | 0.969 | likely_pathogenic |
| 17:7670678:A:C | L344R | 0.960 | likely_pathogenic |
| 17:7670708:C:G | G334A | 0.959 | likely_pathogenic |
| 17:7673545:A:G | F328S | 0.956 | likely_pathogenic |
| 17:7670669:G:T | A347D | 0.953 | likely_pathogenic |
| 17:7670711:C:G | R333P | 0.952 | likely_pathogenic |
| 17:7670715:T:A | I332F | 0.952 | likely_pathogenic |
| 17:7670666:A:G | L348S | 0.951 | likely_pathogenic |
| 17:7670706:G:T | R335S | 0.949 | likely_pathogenic |
| 17:7670697:A:C | F338V | 0.944 | likely_pathogenic |
| 17:7670705:C:G | R335P | 0.936 | likely_pathogenic |
| 17:7673705:C:A | K305N | 0.937 | likely_pathogenic |
| 17:7670687:A:G | F341S | 0.994 | likely_pathogenic |
| 17:7670660:A:G | L350P | 0.928 | likely_pathogenic |
| 17:7670674:A:C | N345K | 0.920 | likely_pathogenic |
| 17:7670664:C:T | E349K | 0.905 | likely_pathogenic |
| 17:7670712:G:T | R333S | 0.874 | likely_pathogenic |
| 17:7670676:T:C | N345D | 0.861 | likely_pathogenic |
| 17:7670687:A:C | F341C | 0.852 | likely_pathogenic |
| 17:7670675:T:A | N345I | 0.850 | likely_pathogenic |
| 17:7670706:G:C | R335G | 0.846 | likely_pathogenic |
| 17:7670663:T:A | E349V | 0.820 | likely_pathogenic |
| 17:7670713:G:C | I332M | 0.817 | likely_pathogenic |
| 17:7670700:G:A | R337C | 0.802 | likely_pathogenic |
| 17:7669633:C:A | K386N | 0.802 | likely_pathogenic |
| 17:7669649:T:A | K381I | 0.796 | likely_pathogenic |
| 17:7669648:T:A | K381N | 0.794 | likely_pathogenic |
| 17:7670663:T:C | E349G | 0.795 | likely_pathogenic |
| 17:7670712:G:C | R333G | 0.780 | likely_pathogenic |
| 17:7670703:C:A | R306L | 0.758 | likely_pathogenic |
| 17:7673540:G:A | L330F | 0.752 | likely_pathogenic |
| 17:7670675:T:G | N345T | 0.745 | likely_pathogenic |
SpliceAI Predictions
Total Splice Variants Assessed: 1,638
TOP 50 Predicted Splice-Altering Variants:
| Variant | Gene | Effect | Delta Score |
|---|
| 17:7669691:C:CC | TP53 | acceptor_gain | 0.95 |
| 17:7669688:TGG:T | TP53 | acceptor_gain | 0.93 |
| 17:7669689:GG:G | TP53 | acceptor_gain | 0.86 |
| 17:7669687:GTGG:G | TP53 | acceptor_gain | 0.81 |
| 17:7669707:C:CT | TP53 | acceptor_gain | 0.81 |
| 17:7668826:C:CT | TP53 | acceptor_gain | 0.79 |
| 17:7669688:TGGC:T | TP53 | acceptor_loss | 0.76 |
| 17:7669690:GCTGT:G | TP53 | acceptor_loss | 0.76 |
| 17:7669691:C:A | TP53 | acceptor_loss | 0.76 |
| 17:7669692:T:A | TP53 | acceptor_loss | 0.76 |
| 17:7669686:GGTGG:G | TP53 | acceptor_gain | 0.71 |
| 17:7670308:A:AC | TP53 | donor_gain | 0.69 |
| 17:7668827:A:T | TP53 | acceptor_gain | 0.69 |
| 17:7668437:T:TC | TP53 | acceptor_gain | 0.68 |
| 17:7668825:T:TG | TP53 | acceptor_gain | 0.68 |
| 17:7668826:C:G | TP53 | acceptor_gain | 0.67 |
| 17:7670329:T:TA | TP53 | donor_gain | 0.59 |
| 17:7669701:C:CT | TP53 | acceptor_gain | 0.59 |
| 17:7670333:TGAG:T | TP53 | donor_gain | 0.59 |
| 17:7668821:A:T | TP53 | acceptor_gain | 0.59 |
| 17:7669693:G:C | TP53 | acceptor_gain | 0.58 |
| 17:7668820:C:T | TP53 | acceptor_gain | 0.55 |
| 17:7669668:G:T | TP53 | donor_gain | 0.49 |
| 17:7668805:C:A | TP53 | acceptor_gain | 0.49 |
| 17:7669708:A:T | TP53 | acceptor_gain | 0.48 |
| 17:7669694:TAGGA:T | TP53 | acceptor_loss | 0.44 |
| 17:7668801:TGG:T | TP53 | acceptor_gain | 0.44 |
| 17:7669696:GGAGA:G | TP53 | acceptor_loss | 0.43 |
| 17:7668437:T:C | TP53 | acceptor_gain | 0.42 |
| 17:7670322:AGGCC:A | TP53 | donor_gain | 0.42 |
| 17:7669700:A:C | TP53 | acceptor_loss | 0.41 |
| 17:7669693:G:GC | TP53 | acceptor_gain | 0.41 |
| 17:7669699:G:GT | TP53 | acceptor_loss | 0.40 |
| 17:7669702:A:T | TP53 | acceptor_gain | 0.38 |
| 17:7668820:CAGT:C | TP53 | acceptor_gain | 0.37 |
| 17:7670161:C:G | TP53 | acceptor_gain | 0.36 |
| 17:7668819:CCAGT:C | TP53 | acceptor_gain | 0.36 |
| 17:7669684:C:A | TP53 | acceptor_loss | 0.35 |
| 17:7669669:AC:A | TP53 | donor_gain | 0.34 |
| 17:7669670:CC:C | TP53 | donor_gain | 0.34 |
| 17:7669683:T:A | TP53 | acceptor_loss | 0.32 |
| 17:7669803:C:A | TP53 | acceptor_gain | 0.32 |
| 17:7669719:A:C | TP53 | acceptor_loss | 0.32 |
| 17:7668803:GGC:G | TP53 | acceptor_gain | 0.32 |
| 17:7668813:C:A | TP53 | acceptor_gain | 0.30 |
| 17:7669698:A:AT | TP53 | acceptor_loss | 0.30 |
| 17:7669703:G:GT | TP53 | acceptor_loss | 0.30 |
| 17:7669695:A:AC | TP53 | acceptor_loss | 0.29 |
| 17:7669726:C:CT | TP53 | acceptor_loss | 0.29 |
| 17:7670651:CCAG:C | TP53 | donor_gain | 0.28 |
Section 7: Biological Pathways & Gene Ontology
Reactome Pathway Membership
Total Pathways: 46
| Pathway ID | Pathway Name |
|---|
| R-HSA-69541 | Stabilization of p53 |
| R-HSA-69895 | Transcriptional activation of cell cycle inhibitor p21 |
| R-HSA-6804116 | TP53 Regulates Transcription of Genes Involved in G1 Cell Cycle Arrest |
| R-HSA-6804114 | TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest |
| R-HSA-69473 | G2/M DNA damage checkpoint |
| R-HSA-69481 | G2/M Checkpoints |
| R-HSA-5693565 | Recruitment and ATM-mediated phosphorylation of repair proteins at DSBs |
| R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes |
| R-HSA-6803204 | TP53 Regulates Transcription of Genes Involved in Cytochrome C Release |
| R-HSA-6803207 | TP53 Regulates Transcription of Caspase Activators and Caspases |
| R-HSA-6803211 | TP53 Regulates Transcription of Death Receptors and Ligands |
| R-HSA-111448 | Activation of NOXA and translocation to mitochondria |
| R-HSA-139915 | Activation of PUMA and translocation to mitochondria |
| R-HSA-5620971 | Pyroptosis |
| R-HSA-2559580 | Oxidative Stress Induced Senescence |
| R-HSA-2559584 | Formation of Senescence-Associated Heterochromatin Foci (SAHF) |
| R-HSA-2559585 | Oncogene Induced Senescence |
| R-HSA-2559586 | DNA Damage/Telomere Stress Induced Senescence |
| R-HSA-5628897 | TP53 Regulates Metabolic Genes |
| R-HSA-6804754 | Regulation of TP53 Expression |
| R-HSA-6804756 | Regulation of TP53 Activity through Phosphorylation |
| R-HSA-6804757 | Regulation of TP53 Degradation |
| R-HSA-6804758 | Regulation of TP53 Activity through Acetylation |
| R-HSA-6804759 | Regulation of TP53 Activity through Association with Co-factors |
| R-HSA-6804760 | Regulation of TP53 Activity through Methylation |
| R-HSA-6811555 | PI5P Regulates TP53 Acetylation |
| R-HSA-349425 | Autodegradation of the E3 ubiquitin ligase COP1 |
| R-HSA-5689880 | Ub-specific processing proteases |
| R-HSA-5689896 | Ovarian tumor domain proteases |
| R-HSA-3232118 | SUMOylation of transcription factors |
| R-HSA-390471 | Association of TriC/CCT with target proteins during biosynthesis |
| R-HSA-1912408 | Pre-NOTCH Transcription and Translation |
| R-HSA-6785807 | Interleukin-4 and Interleukin-13 signaling |
| R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint |
| R-HSA-8853884 | Transcriptional Regulation by VENTX |
| R-HSA-8941855 | RUNX3 regulates CDKN1A transcription |
| R-HSA-8943724 | Regulation of PTEN gene transcription |
| R-HSA-70635 | Urea cycle |
| R-HSA-983231 | Factors involved in megakaryocyte development and platelet production |
| R-HSA-9758274 | Regulation of NF-kappa B signaling |
| R-HSA-9819196 | Zygotic genome activation (ZGA) |
| R-HSA-9833482 | PKR-mediated signaling |
| R-HSA-9723905 | Loss of function of TP53 in cancer due to loss of tetramerization ability (Disease) |
| R-HSA-9725370 | Signaling by ALK fusions and activated point mutants (Disease) |
| R-HSA-6803205 | TP53 regulates transcription of additional cell death genes |
| R-HSA-6804115 | TP53 regulates transcription of additional cell cycle genes |
Gene Ontology Annotations
Total GO Annotations: 203
Biological Process (TOP 20 of ~120 terms)
| GO ID | Term Name |
|---|
| GO:0006915 | apoptotic process |
| GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
| GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator |
| GO:0043065 | positive regulation of apoptotic process |
| GO:0030330 | DNA damage response, signal transduction by p53 class mediator |
| GO:0006974 | DNA damage response |
| GO:0006302 | double-strand break repair |
| GO:0008285 | negative regulation of cell population proliferation |
| GO:0045930 | negative regulation of mitotic cell cycle |
| GO:0031571 | mitotic G1 DNA damage checkpoint signaling |
| GO:0045944 | positive regulation of transcription by RNA polymerase II |
| GO:0045892 | negative regulation of DNA-templated transcription |
| GO:0000122 | negative regulation of transcription by RNA polymerase II |
| GO:0090398 | cellular senescence |
| GO:0090399 | replicative senescence |
| GO:0090403 | oxidative stress-induced premature senescence |
| GO:0006914 | autophagy |
| GO:0000423 | mitophagy |
| GO:0001836 | release of cytochrome c from mitochondria |
| GO:0090200 | positive regulation of release of cytochrome c from mitochondria |
Molecular Function (TOP 20 of ~40 terms)
| GO ID | Term Name |
|---|
| GO:0003700 | DNA-binding transcription factor activity |
| GO:0000981 | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO:0001228 | DNA-binding transcription activator activity, RNA polymerase II-specific |
| GO:0001227 | DNA-binding transcription repressor activity, RNA polymerase II-specific |
| GO:0003677 | DNA binding |
| GO:0003682 | chromatin binding |
| GO:0000976 | transcription cis-regulatory region binding |
| GO:0000977 | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
| GO:0001046 | core promoter sequence-specific DNA binding |
| GO:0005515 | protein binding |
| GO:0002039 | p53 binding |
| GO:0046982 | protein heterodimerization activity |
| GO:0042802 | identical protein binding |
| GO:0008270 | zinc ion binding |
| GO:0005507 | copper ion binding |
| GO:0019899 | enzyme binding |
| GO:0031625 | ubiquitin protein ligase binding |
| GO:0042826 | histone deacetylase binding |
| GO:0035033 | histone deacetylase regulator activity |
| GO:0071889 | 14-3-3 protein binding |
Cellular Component (TOP 20 of ~25 terms)
| GO ID | Term Name |
|---|
| GO:0005634 | nucleus |
| GO:0005654 | nucleoplasm |
| GO:0005730 | nucleolus |
| GO:0005737 | cytoplasm |
| GO:0005829 | cytosol |
| GO:0005739 | mitochondrion |
| GO:0005759 | mitochondrial matrix |
| GO:0000785 | chromatin |
| GO:0016605 | PML body |
| GO:0016604 | nuclear body |
| GO:0016363 | nuclear matrix |
| GO:0005657 | replication fork |
| GO:0005667 | transcription regulator complex |
| GO:0017053 | transcription repressor complex |
| GO:0005813 | centrosome |
| GO:0005856 | cytoskeleton |
| GO:0005783 | endoplasmic reticulum |
| GO:0035861 | site of double-strand break |
| GO:0043073 | germ cell nucleus |
| GO:0016020 | membrane |
Section 8: Protein Interactions & Molecular Networks
Protein-Protein Interactions
Total STRING Interactions: 14,764
Total BioGRID Interactions: 6,087
Total IntAct Interactions: 1,863
TOP 50 Highest-Confidence Interacting Proteins (STRING)
| UniProt | Gene | Score | Description |
|---|
| P04637 | TP53 | 999 | Self-interaction (homodimerization) |
| P10415 | BCL2 | 999 | Apoptosis regulator BCL-2 |
| P38398 | BRCA1 | 999 | Breast cancer type 1 susceptibility protein |
| Q00987 | MDM2 | 999 | E3 ubiquitin-protein ligase Mdm2 |
| O15151 | MDM4 | 998 | Protein Mdm4 (MDMX) |
| Q07817 | BCL2L1 | 998 | Bcl-2-like protein 1 (BCL-XL) |
| Q09472 | EP300 | 998 | Histone acetyltransferase p300 |
| P01106 | MYC | 997 | Myc proto-oncogene protein |
| Q12888 | TP53BP1 | 997 | TP53-binding protein 1 |
| P07900 | HSP90AA1 | 995 | Heat shock protein 90 |
| Q06609 | RAD51 | 995 | DNA repair protein RAD51 |
| P08238 | HSP90AB1 | 994 | Heat shock protein 90-beta |
| P20248 | CCNA2 | 994 | Cyclin-A2 |
| P26358 | DNMT1 | 994 | DNA methyltransferase 1 |
| Q13547 | HDAC1 | 994 | Histone deacetylase 1 |
| Q16665 | HIF1A | 994 | Hypoxia-inducible factor 1-alpha |
| Q13625 | TP53BP2 | 996 | Apoptosis-stimulating of p53 protein 2 |
| Q92793 | CREBBP | 996 | CREB-binding protein (CBP) |
| P78355 | PITX2 | 993 | Pituitary homeobox 2 |
| O43524 | FOXO3 | 992 | Forkhead box protein O3 |
| O96017 | CHEK2 | 992 | Serine/threonine-protein kinase Chk2 |
| P05412 | JUN | 992 | Transcription factor AP-1 |
| P16220 | CREB1 | 992 | cAMP response element-binding protein |
| P98177 | FOXO4 | 992 | Forkhead box protein O4 |
| Q9NRR4 | ATM | 992 | Serine-protein kinase ATM |
| P04271 | S100B | 990 | Protein S100-B |
| P30036 | AR | 990 | Androgen receptor |
| P30405 | PPIF | 990 | Peptidyl-prolyl cis-trans isomerase F |
| Q96EB6 | SIRT1 | 990 | NAD-dependent protein deacetylase sirtuin-1 |
| P19838 | NFKB1 | 989 | Nuclear factor NF-kappa-B p105 subunit |
| P42858 | HTT | 989 | Huntingtin |
| P17844 | DDX5 | 987 | Probable ATP-dependent RNA helicase DDX5 |
| P51959 | CCNG1 | 984 | Cyclin-G1 |
| P26447 | S100A4 | 981 | Protein S100-A4 |
| P49841 | GSK3B | 981 | Glycogen synthase kinase-3 beta |
| Q99608 | ATR | 980 | Serine/threonine-protein kinase ATR |
| P34932 | HSPA4 | 979 | Heat shock 70 kDa protein 4 |
| O14965 | AURKA | 978 | Aurora kinase A |
| Q7Z6E9 | USP7 | 976 | Ubiquitin carboxyl-terminal hydrolase 7 |
| P51587 | BRCA2 | 975 | Breast cancer type 2 susceptibility protein |
| Q13315 | ATM | 975 | Serine-protein kinase ATM |
| P03372 | ESR1 | 974 | Estrogen receptor |
| Q01094 | E2F1 | 974 | Transcription factor E2F1 |
| O95863 | SNAI1 | 973 | Zinc finger protein SNAI1 |
| P29034 | S100A2 | 973 | Protein S100-A2 |
| Q93009 | USP7 | 973 | Ubiquitin carboxyl-terminal hydrolase 7 |
| P20226 | TBP | 972 | TATA-box-binding protein |
| Q16666 | IFI16 | 971 | Gamma-interferon-inducible protein 16 |
| P40763 | STAT3 | 970 | Signal transducer and activator of transcription 3 |
| P42771 | CDKN2A | 970 | Cyclin-dependent kinase inhibitor 2A (p16) |
Protein Structural Similarity (ESM2 Embedding, Top 20)
| UniProt | Similarity | Description |
|---|
| O57538 | 1.0000 | Hamster Trp53 |
| P13481 | 1.0000 | Pig Tp53 |
| P56423 | 1.0000 | Orangutan TP53 |
| P56424 | 1.0000 | Chimpanzee TP53 |
| P61260 | 1.0000 | Gorilla TP53 |
| P67938 | 1.0000 | Rhesus macaque TP53 |
| P67939 | 1.0000 | Crab-eating macaque TP53 |
| Q92143 | 1.0000 | Rabbit Tp53 |
| Q8N9I9 | 1.0000 | Human TP53 isoform |
| Q5REG4 | 1.0000 | Pongo pygmaeus TP53 |
| Q80V91 | 0.9999 | Mouse Trp53 isoform |
| Q5U2W6 | 0.9999 | Human TP63 |
| Q91VU8 | 0.9999 | Mouse Trp63 |
| P04637 | 0.9998 | Human TP53 (self) |
| Q15306 | 0.9997 | Human TP63 |
| Q02556 | 0.9998 | Human TP73 |
| Q64287 | 0.9997 | Mouse Trp73 |
| O09185 | 0.9997 | Guinea pig Tp53 |
| Q00366 | 0.9997 | Sheep Tp53 |
| Q9TTA1 | 0.9996 | Dog Tp53 |
Section 9: Transcription Factor Regulatory Data
TP53 as a Transcription Factor
JASPAR Binding Motifs:
| Motif ID | Name | Collection | Class | Family |
|---|
| MA0106.1 | TP53 | CORE | p53 domain factors | p53-related factors |
| MA0106.2 | TP53 | CORE | p53 domain factors | p53-related factors |
| MA0106.3 | TP53 | CORE | p53 domain factors | p53-related factors |
Upstream Regulators of TP53 (CollecTRI, Top 50 TFs)
| TF | Regulation | Confidence |
|---|
| E2F1 | Activation | High |
| MYC | Activation | High |
| MYCN | Activation | High |
| HIF1A | Activation | High |
| EGR1 | Activation | High |
| HOXA5 | Activation | High |
| HOXA10 | Activation | High |
| ATF3 | Unknown | High |
| CTCF | Unknown | High |
| DNMT1 | Unknown | High |
| ESR1 | Repression | High |
| ETS1 | Unknown | High |
| ETS2 | Unknown | High |
| FOS | Unknown | High |
| IRF1 | Unknown | High |
| JUN | Repression | High |
| AP1 | Repression | High |
| KLF2 | Unknown | High |
| MAF | Activation | High |
| MAX | Unknown | High |
| NFKB1 | Unknown | High |
| NFKB | Unknown | High |
| NKX3-1 | Unknown | High |
| NR2E3 | Unknown | High |
| BHLHE40 | Unknown | High |
| CEBPB | Unknown | High |
| BCL6 | Unknown | High |
| IRF3 | Unknown | High |
| CREB1 | Activation | - |
| CREBBP | Unknown | - |
| E2F2 | Activation | - |
| NF1 | Activation | - |
| KLF4 | Activation | Low |
| KLF6 | Activation | - |
| ING1 | Activation | - |
| ING4 | Activation | - |
| FOXO1 | Activation | Low |
| GATA2 | Activation | Low |
| GLI1 | Activation | Low |
| HDAC1 | Repression | - |
| HDAC9 | Repression | - |
| EZH2 | Repression | Low |
| FOXM1 | Repression | - |
| ELF4 | Repression | - |
| HOXA11 | Repression | - |
| IRF8 | Repression | - |
| NR3C1 | Repression | - |
| DRAM2 | Repression | - |
| ABL1 | Activation | - |
| BMAL1 | Activation | - |
Downstream Target Genes (Genes regulated BY TP53)
Total Target Count: ~1,200+ genes (from CollecTRI)
TP53 regulates a vast network of genes involved in:
- Cell cycle arrest (CDKN1A/p21, GADD45A, SFN)
- Apoptosis (BAX, BBC3/PUMA, PMAIP1/NOXA, FAS, DR5)
- DNA repair (DDB2, XPC, RRM2B)
- Metabolism (TIGAR, SCO2, GLS2)
- Autophagy (DRAM1)
- Senescence (SERPINE1, PML)
Section 10: Drug & Pharmacology Data
ChEMBL Target Information
Target Types:
| ChEMBL Target ID | Type | Description |
|---|
| CHEMBL4096 | SINGLE PROTEIN | Cellular tumor antigen p53 |
| CHEMBL1907611 | PROTEIN-PROTEIN INTERACTION | p53/MDM2 |
| CHEMBL2221344 | PROTEIN-PROTEIN INTERACTION | p53/MDM4 |
| CHEMBL3301383 | PROTEIN-PROTEIN INTERACTION | CBP/p53 |
| CHEMBL3883306 | PROTEIN-PROTEIN INTERACTION | MDM2/MDMX-p53 |
| CHEMBL3885543 | PROTEIN-PROTEIN INTERACTION | p53/DAPK1 |
| CHEMBL3885544 | PROTEIN-PROTEIN INTERACTION | p53/Cyclophilin D |
| CHEMBL3885545 | PROTEIN-PROTEIN INTERACTION | p53/RPA70 |
| CHEMBL4879538 | PROTEIN-PROTEIN INTERACTION | Cereblon/p53/MDM2 |
| CHEMBL6066147 | PROTEIN-PROTEIN INTERACTION | BRD4/p53 |
| CHEMBL6066834 | PROTEIN-PROTEIN INTERACTION | CBP/p300/p53 |
Total ChEMBL Bioactivities: 28,174
TOP 30 Drug/Compound Molecules by Development Phase
| ChEMBL ID | Name | Type | Phase |
|---|
| CHEMBL1014 | CANDESARTAN CILEXETIL | Small molecule | 4 (Approved) |
| CHEMBL1018 | DIENESTROL | Small molecule | 4 (Approved) |
| CHEMBL104 | CLOTRIMAZOLE | Small molecule | 4 (Approved) |
| CHEMBL107 | COLCHICINE | Small molecule | 4 (Approved) |
| CHEMBL1070 | NABUMETONE | Small molecule | 4 (Approved) |
| CHEMBL1082607 | SALMETEROL XINAFOATE | Small molecule | 4 (Approved) |
| CHEMBL1083993 | AMIODARONE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1103 | FURAZOLIDONE | Small molecule | 4 (Approved) |
| CHEMBL1113 | AMOXAPINE | Small molecule | 4 (Approved) |
| CHEMBL1116 | RALOXIFENE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1200326 | NICARDIPINE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1200348 | SULCONAZOLE NITRATE | Small molecule | 4 (Approved) |
| CHEMBL1200471 | PYRITHIONE ZINC | Small molecule | 4 (Approved) |
| CHEMBL1200559 | LACTIC ACID | Small molecule | 4 (Approved) |
| CHEMBL1200585 | OXYMETHOLONE | Small molecule | 4 (Approved) |
| CHEMBL1200596 | CHLOROXINE | Small molecule | 4 (Approved) |
| CHEMBL1200627 | PROPIOLACTONE | Small molecule | 4 (Approved) |
| CHEMBL1200710 | CLOMIPRAMINE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1200868 | PHENYL AMINOSALICYLATE | Small molecule | 4 (Approved) |
| CHEMBL1200916 | THIORIDAZINE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1200964 | AMITRIPTYLINE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1200970 | ETHOPROPAZINE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1201001 | MECHLORETHAMINE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1201049 | ECONAZOLE NITRATE | Small molecule | 4 (Approved) |
| CHEMBL1201102 | TRIFLUPROMAZINE HYDROCHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1201154 | PROCHLORPERAZINE EDISYLATE | Small molecule | 4 (Approved) |
| CHEMBL121663 | DEQUALINIUM CHLORIDE | Small molecule | 4 (Approved) |
| CHEMBL1228 | OXYPHENBUTAZONE ANHYDROUS | Small molecule | 4 (Approved) |
| CHEMBL1189 | DIETHYLAMINE | Small molecule | 3 (Phase III) |
| CHEMBL1192517 | BIFEMELANE | Small molecule | 2 (Phase II) |
PharmGKB Gene Information
| Property | Value |
|---|
| PharmGKB ID | PA36679 |
| Symbol | TP53 |
| VIP Gene | Yes (Very Important Pharmacogene) |
| Has Variant Annotations | Yes |
| Has CPIC Guideline | No |
| Chromosome | chr17 |
Section 11: Expression Profiles
Expression Overview (Bgee)
| Property | Value |
|---|
| Gene | ENSG00000141510 (TP53) |
| Species | Homo sapiens |
| Expression Breadth | Ubiquitous |
| Total Present Calls | 223 |
| Total Absent Calls | 58 |
| Total Conditions | 281 |
| Max Expression Score | 95.11 |
| Average Expression Score | 77.62 |
| Gold Quality Count | 244 |
TOP 30 Tissues by Expression Score
| Tissue/Cell Type (UBERON/CL) | Expression | Score | Quality |
|---|
| Ventricular zone (UBERON:0003053) | Present | 95.11 | Gold |
| Ganglionic eminence (UBERON:0004023) | Present | 94.13 | Gold |
| Tendon of biceps brachii (UBERON:0008188) | Present | 92.63 | Gold |
| Monocyte (CL:0000576) | Present | 90.86 | Gold |
| Stromal cell of endometrium (CL:0002255) | Present | 90.85 | Gold |
| Leukocyte (CL:0000738) | Present | 90.78 | Gold |
| Mononuclear cell (CL:0000842) | Present | 90.55 | Gold |
| Skin of abdomen (UBERON:0001416) | Present | 90.47 | Gold |
| Rectum (UBERON:0001052) | Present | 90.40 | Gold |
| Granulocyte (CL:0000094) | Present | 90.35 | Gold |
| Skin of leg (UBERON:0001511) | Present | 90.30 | Gold |
| Smooth muscle tissue (UBERON:0001135) | Present | 90.23 | Gold |
| Mucosa of transverse colon (UBERON:0004991) | Present | 90.20 | Gold |
| Embryo (UBERON:0000922) | Present | 90.05 | Gold |
| Sural nerve (UBERON:0015488) | Present | 89.63 | Gold |
| Right ovary (UBERON:0002118) | Present | 89.59 | Gold |
| Left ovary (UBERON:0002119) | Present | 89.12 | Gold |
| Esophagus mucosa (UBERON:0002469) | Present | 88.83 | Gold |
| Colonic epithelium (UBERON:0000397) | Present | 88.70 | Gold |
| Zone of skin (UBERON:0000014) | Present | 88.47 | Gold |
| Left uterine tube (UBERON:0001303) | Present | 88.31 | Gold |
| Vermiform appendix (UBERON:0001154) | Present | 88.27 | Gold |
| Right coronary artery (UBERON:0001625) | Present | 88.24 | Gold |
| Spleen (UBERON:0002106) | Present | 88.22 | Gold |
| Ovary (UBERON:0000992) | Present | 88.01 | Gold |
| Lymph node (UBERON:0000029) | Present | 87.97 | Gold |
| Ectocervix (UBERON:0012249) | Present | 87.88 | Gold |
| Vagina (UBERON:0000996) | Present | 87.72 | Gold |
| Body of uterus (UBERON:0009853) | Present | 87.70 | Gold |
| Transverse colon (UBERON:0001157) | Present | 87.60 | Gold |
Expression Pattern Summary
TP53 shows ubiquitous expression across virtually all human tissues and cell types, consistent with its role as a fundamental tumor suppressor and cell cycle regulator. Highest expression is
observed in:
- Neural progenitor regions (ventricular zone, ganglionic eminence)
- Immune cells (monocytes, leukocytes, granulocytes)
- Epithelial tissues (skin, colon, reproductive tract)
- Embryonic tissues
Section 12: Disease Associations
GenCC Gene-Disease Associations
| Disease | OMIM/MONDO ID | Classification | Inheritance | Source |
|---|
| Li-Fraumeni syndrome 1 | OMIM:151623 | Definitive | AD | Multiple |
| Breast cancer | MONDO:0007254 | Definitive | AD | Ambry |
| Adrenocortical carcinoma, hereditary | OMIM:202300 | Strong | AD | Ambry |
| Sarcoma | MONDO:0005089 | Strong | AD | Genomics England |
| Colorectal cancer | OMIM:114500 | Moderate | AD | Ambry |
| Bone marrow failure syndrome 5 | OMIM:618165 | Moderate | AD | Ambry |
| Choroid plexus carcinoma | ORPHANET:251899 | Supportive | AD | Orphanet |
Orphanet Disease Associations (20 diseases)
| Orphanet ID | Disease Name | Type | Gene Count |
|---|
| 524 | Li-Fraumeni syndrome | Disease | 4 |
| 668 | Osteosarcoma | Disease | 4 |
| 1501 | Adrenocortical carcinoma | Disease | 7 |
| 1333 | Familial pancreatic carcinoma | Disease | 9 |
| 145 | Hereditary breast and/or ovarian cancer syndrome | Disease | 15 |
| 210159 | Adult hepatocellular carcinoma | Disease | 9 |
| 2807 | Papilloma of choroid plexus | Disease | 1 |
| 251899 | Choroid plexus carcinoma | Disease | 1 |
| 251576 | Gliosarcoma | Histopathological subtype | 12 |
| 251579 | Giant cell glioblastoma | Histopathological subtype | 13 |
| 293199 | Pleomorphic rhabdomyosarcoma | Clinical subtype | 2 |
| 99756 | Alveolar rhabdomyosarcoma | Clinical subtype | 5 |
| 99757 | Embryonal rhabdomyosarcoma | Clinical subtype | 4 |
| 3318 | Essential thrombocythemia | Disease | 6 |
| 52688 | Myelodysplastic syndrome | Clinical group | 1 |
| 585909 | B-lymphoblastic leukemia/lymphoma with t(9;22) | Etiological subtype | 7 |
| 667662 | Breast implant-associated anaplastic large cell lymphoma | Disease | 7 |
| 67038 | B-cell chronic lymphocytic leukemia | Disease | 10 |
| 70573 | Small cell lung cancer | Disease | 3 |
| 96253 | Cushing disease | Disease | 7 |
HPO Phenotype Associations (Top 50 of 224)
| HPO ID | Phenotype Term |
|---|
| HP:0000006 | Autosomal dominant inheritance |
| HP:0001442 | Typified by somatic mosaicism |
| HP:0002664 | Neoplasm |
| HP:0001909 | Leukemia |
| HP:0002488 | Acute leukemia |
| HP:0002863 | Myelodysplasia |
| HP:0002665 | Lymphoma |
| HP:0002669 | Osteosarcoma |
| HP:0002859 | Rhabdomyosarcoma |
| HP:0002885 | Medulloblastoma |
| HP:0002888 | Ependymoma |
| HP:0002861 | Melanoma |
| HP:0002671 | Basal cell carcinoma |
| HP:0002890 | Thyroid carcinoma |
| HP:0001402 | Hepatocellular carcinoma |
| HP:0002667 | Nephroblastoma |
| HP:0002891 | Uterine leiomyosarcoma |
| HP:0001249 | Intellectual disability |
| HP:0001263 | Global developmental delay |
| HP:0001510 | Growth delay |
| HP:0000252 | Microcephaly |
| HP:0000238 | Hydrocephalus |
| HP:0001250 | Seizure |
| HP:0002069 | Bilateral tonic-clonic seizure |
| HP:0000726 | Dementia |
| HP:0002354 | Memory impairment |
| HP:0000709 | Psychosis |
| HP:0000725 | Psychotic episodes |
| HP:0000716 | Depression |
| HP:0000739 | Anxiety |
| HP:0000737 | Irritability |
| HP:0000712 | Emotional lability |
| HP:0001903 | Anemia |
| HP:0001872 | Abnormality of thrombocytes |
| HP:0001894 | Thrombocytosis |
| HP:0001974 | Increased total leukocyte count |
| HP:0001888 | Decreased total lymphocyte count |
| HP:0001892 | Abnormal bleeding |
| HP:0000939 | Osteoporosis |
| HP:0002756 | Pathologic fracture |
| HP:0002797 | Osteolysis |
| HP:0002750 | Delayed skeletal maturation |
| HP:0000819 | Diabetes mellitus |
| HP:0000822 | Hypertension |
| HP:0001658 | Myocardial infarction |
| HP:0001297 | Stroke |
| HP:0002326 | Transient ischemic attack |
| HP:0002315 | Headache |
| HP:0002076 | Migraine |
| HP:0002206 | Pulmonary fibrosis |
GWAS Associations (Top 30 of 50)
| Study ID | Trait | P-value | Mapped Gene |
|---|
| GCST004347_18 | Glioma | 9×10⁻³⁸ | TP53 |
| GCST006462_47 | Uterine fibroids | 4×10⁻³⁷ | TP53 |
| GCST008423_10 | Uterine fibroids | 3×10⁻³³ | TP53 |
| GCST008871_42 | Basal cell carcinoma | 6×10⁻³³ | TP53 |
| GCST009158_4 | Uterine fibroids | 7×10⁻³¹ | TP53 |
| GCST009375_3 | Mosaic loss of chromosome Y | 3×10⁻²⁸ | TP53 |
| GCST008870_8 | Keratinocyte cancer (MTAG) | 4×10⁻²⁵ | TP53 |
| GCST004349_13 | Glioblastoma | 5×10⁻²⁹ | TP53 |
| GCST004348_4 | Non-glioblastoma glioma | 5×10⁻²⁷ | TP53 |
| GCST090013410_7 | Basal cell carcinoma | 8×10⁻²⁷ | TP53 |
| GCST007269_171 | Pulse pressure | 8×10⁻²³ | TP53 |
| GCST090002390_120 | Mean corpuscular hemoglobin | 1×10⁻²² | TP53 |
| GCST090002397_710 | Mean spheric corpuscular volume | 2×10⁻²² | TP53 |
| GCST002331_9 | Basal cell carcinoma | 4×10⁻²² | TP53 |
| GCST090002403_320 | Red blood cell count | 3×10⁻²¹ | TP53 |
| GCST090002392_490 | Mean corpuscular volume | 1×10⁻²⁰ | TP53 |
| GCST001250_1 | Basal cell carcinoma | 2×10⁻²⁰ | TP53 |
| GCST002842_7 | Basal cell carcinoma | 1×10⁻²⁰ | TP53 |
| GCST005931_4 | Glioma | 3×10⁻¹⁷ | TP53 |
| GCST006480_12 | Glioblastoma (age-stratified) | 9×10⁻¹⁶ | TP53 |
| GCST002925_8 | Sex hormone levels | 1×10⁻¹⁵ | TP53 |
| GCST007268_21 | Diastolic blood pressure | 3×10⁻¹⁵ | TP53 |
| GCST005932_14 | Glioblastoma | 1×10⁻¹⁴ | TP53 |
| GCST007096_39 | Pulse pressure | 4×10⁻¹³ | TP53 |
| GCST002568_2 | Esophageal squamous cell carcinoma | 3×10⁻¹³ | ATP1B2 |
| GCST004280_49 | Diastolic blood pressure | 1×10⁻¹³ | SLC2A4 |
| GCST005931_5 | Glioma | 2×10⁻¹² | TP53 |
| GCST090002396_317 | Mean reticulocyte volume | 2×10⁻¹² | TP53 |
| GCST010303_20 | Nevus count or cutaneous melanoma | 3×10⁻¹² | TP53 |
| GCST008362_2 | Birth weight | 2×10⁻¹¹ | TP53 |
SUMMARY STATISTICS
| Category | Count |
|---|
| Gene Identifiers | 4 major databases |
| Transcripts (Ensembl) | 39 |
| RefSeq Transcripts (Human) | 21 mRNA + 21 protein |
| CCDS IDs | 12 |
| Exons (Canonical) | 11 |
| UniProt Accessions | 19 (1 reviewed) |
| InterPro Domains | 9 |
| Pfam Domains | 4 |
| PDB Structures | 297 |
| Orthologs | 4 model organisms |
| ClinVar Variants | 3,850 |
| AlphaMissense Predictions | 2,569 |
| SpliceAI Predictions | 1,638 |
| Reactome Pathways | 46 |
| GO Annotations | 203 |
| STRING Interactions | 14,764 |
| BioGRID Interactions | 6,087 |
| ChEMBL Bioactivities | 28,174 |
| GWAS Associations | 50 |
| HPO Phenotypes | 224 |
| Orphanet Diseases | 20 |
| GenCC Disease Links | 11 |
I have compiled a comprehensive cross-database identifier and functional mapping reference for human TP53. This definitive lookup resource includes:
Key Highlights:
- 297 PDB experimental structures with methods ranging from X-ray (1.01-4.23 Å resolution) to NMR and Cryo-EM
- 3,850 ClinVar variants with ~400+ classified as pathogenic
- 2,569 AlphaMissense missense predictions with pathogenicity scores
- 1,638 SpliceAI splice effect predictions
- 14,764 STRING protein interactions and 6,087 BioGRID interactions
- 46 Reactome pathways covering cell cycle, apoptosis, DNA damage response, and senescence
- 203 GO annotations across biological process, molecular function, and cellular component
- 50 GWAS associations linking TP53 to glioma, basal cell carcinoma, uterine fibroids, and blood traits
- Ubiquitous expression across all 281 conditions tested (Bgee)
The reference provides all identifiers in a structured format suitable for computational lookup, cross-database linking, and research annotation purposes.